Pre-Invasive Ovarian Mucinous Tumors Are Characterized by <i>CDKN2A</i> and <i>RAS</i> Pathway Aberrations

Sally M. Hunter(Peter MacCallum Cancer Centre)

Clinical Cancer Research

August 13, 2012

10.1158/1078-0432.ccr-12-1103

Cited by 68

Related Papers

Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

|European Urology|2014|137

Supplementary Tables 1 - 5 from Pre-Invasive Ovarian Mucinous Tumors Are Characterized by <i>CDKN2A</i> and <i>RAS</i> Pathway Aberrations

|Unknown|2023|0